Kidney transplant (KT) is the first therapeutic option for most patients with chronic renal failure that requires renal function replacement. The main complication associated with renal graft loss is immune rejection. The T regulatory pathways play a key role in this process, and abnormalities in some of these molecules could participate in the graft rejection. In this paper, our group performed an exploratory analysis of the behavior of the coinducible molecules (CD28, CTLA-4, ICOS, PD-1) in patients with KT rejection and control KT patients without rejection. The Mann-Whitney U test, used for 2 groups, showed significant differences (P = .0005), indicating that PD-1 is underexpressed in patients with allograft rejection. No differences were found in CD28+, regulatory T cells (T reg), CTLA-4, and ICOS, so we are proposing that PD-1 is a key player in the immunotolerance phenomenon and its underexpression participates in the rejection process. More research needs to be performed on this topic.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.transproceed.2020.02.019 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Extraordinary diversity of the CD28/CTLA4 family across jawed vertebrates.
Front Immunol
November 2024
Université Paris-Saclay, INRAE, UVSQ, VIM, Jouy-en-Josas, France.
Members of the CD28 family are critical for the control of immune cell activation. While CD28 and CTLA4 were previously identified in teleost fish, most members of the CD28 family have been described only in tetrapods. Using a comparative genomics approach, we found (co)orthologs of all members of the CD28 family both in Chondrichthyes and basal Osteichthyes groups, but not in Agnathans.
View Article and Find Full Text PDFComparing neoantigen cancer vaccines and immune checkpoint therapy unveils an effective vaccine and anti-TREM2 macrophage-targeting dual therapy.
Cell Rep
November 2024
Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:
The goal of therapeutic cancer vaccines and immune checkpoint therapy (ICT) is to promote T cells with anti-tumor capabilities. Here, we compared mutant neoantigen (neoAg) peptide-based vaccines with ICT in preclinical models. NeoAg vaccines induce the most robust expansion of proliferating and stem-like PD-1TCF-1 neoAg-specific CD8 T cells in tumors.
View Article and Find Full Text PDFCharacterization of novel CD8 regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease.
Cell Mol Life Sci
August 2024
Graduate Institute of Clinical Medicine, College of Medicine, National Taiwan University, Taipei, Taiwan.
Article Synopsis
- - Dysregulation of the mucosal immune system is key in inflammatory bowel diseases (IBDs), with regulatory T cells (Tregs) crucial for maintaining intestinal balance and suppressing colitis inflammation.
- - Previous research found a new type of Treg (Treg-of-B cells) that protects against colitis by regulating cytokines, leading to the investigation of similar cells in the CD8 T-cell population.
- - The study found that these CD8 Treg-of-B cells express key regulatory proteins (like LAG3 and PD-1), produce inhibitory cytokines (like IL-10), and can suppress T cell activity, suggesting potential for new treatments for IBDs.
CAR-NKT Cells in Asthma: Use of NKT as a Promising Cell for CAR Therapy.
Clin Rev Allergy Immunol
June 2024
Cancer Gene therapy Research Center, Zanjan University of Medical Sciences, Zanjan, Iran.
NKT cells, unique lymphocytes bridging innate and adaptive immunity, offer significant potential for managing inflammatory disorders like asthma. Activating iNKT induces increasing IFN-γ, TGF-β, IL-2, and IL-10 potentially suppressing allergic asthma. However, their immunomodulatory effects, including granzyme-perforin-mediated cytotoxicity, and expression of TIM-3 and TRAIL warrant careful consideration and targeted approaches.
View Article and Find Full Text PDFTherapeutic potential of co-signaling receptor modulation in hepatitis B.
Cell
July 2024
Division of Immunology, Transplantation, and Infectious Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy; Vita-Salute San Raffaele University, Milan, Italy. Electronic address:
Reversing CD8 T cell dysfunction is crucial in treating chronic hepatitis B virus (HBV) infection, yet specific molecular targets remain unclear. Our study analyzed co-signaling receptors during hepatocellular priming and traced the trajectory and fate of dysfunctional HBV-specific CD8 T cells. Early on, these cells upregulate PD-1, CTLA-4, LAG-3, OX40, 4-1BB, and ICOS.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!